Comprehensive Relationships Between Gut Microbiome and Faecal Metabolome in Individuals with Type 2 Diabetes and Its Complications

Overview

Journal Endocrine

Specialty Endocrinology

Date 2019 Oct 9

PMID 31591683

Citations 94

Authors

Lijuan Zhao

Hongxiang Lou

Ying Peng

Shihong Chen

Yulong Zhang

Xiaobo Li

Affiliations

Soon will be listed here.

Abstract

Purpose: As the treatment regimens such as metformin could confound the correlation between type 2 diabetes (T2D) and gut microbiome, we should revisit the relationship between gut microbiota and T2D patients who are not currently treated with metformin.

Methods: The study recruited 65 T2D patients: 49 with and 16 without diabetic complications, and 35 healthy controls. We sequenced the 16S rRNA V3-V4 region of gut microbiota and detected metabolites based on liquid chromatography mass spectrometry (LC/MS) and gas chromatography mass spectrometry (GC/MS) in faecal samples.

Results: The composition of both the gut microbiota and faecal metabolites changed significantly with T2D patients. The abundance of Proteobacteria and the ratio of Firmicutes/Bacteroidetes were higher in T2D patients than healthy subjects, and the short chain fatty acids (SCFAs), bile acids and lipids of T2D patients were significantly disordered. Moreover, the abundances of certain SCFA-producing bacteria (Lachnospiraceae and Ruminococcaceae etc.) were significantly increased in T2D patients, while the faecal SCFAs concentrations were significantly decreased. It's suggested that the role of SCFA-producing bacteria was not simply to produce SCFAs. Then we identified 44 microbial modules to explore the correlations between the gut microbiota and metabolic traits. Specially, most modules including certain SCFA-producing bacteria were comprehensively correlated to body mass index, the levels of blood glucose, blood pressure, blood cholesterol and faecal bile acids and lipids.

Conclusions: Our study identified the relationships between the gut microbiota and faecal metabolites, and provided a resource for future studies to understand host-gut microbiota interactions in T2D.

Citing Articles

Circulating short-chain and branched short-chain fatty acids and the risk of incident type 2 diabetes: findings from the 4C study.

Wang S, Lin H, Jia X, Lin Y, Hu C, Li M Life Metab. 2025; 4(2):loaf001.

PMID: 40078932 PMC: 11897982. DOI: 10.1093/lifemeta/loaf001.

Flavonoid-Rich Extracts from Chuju ( L.) Alleviate the Disturbance of Glycolipid Metabolism on Type 2 Diabetic Mice via Modulating the Gut Microbiota.

Yin Y, Nie W, Tang Z, Zhu S Foods. 2025; 14(5).

PMID: 40077469 PMC: 11898795. DOI: 10.3390/foods14050765.

A systematic review on gut microbiota in type 2 diabetes mellitus.

Chong S, Lin M, Chong D, Jensen S, Lau N Front Endocrinol (Lausanne). 2025; 15:1486793.

PMID: 39897957 PMC: 11782031. DOI: 10.3389/fendo.2024.1486793.

Diabetes and gut microbiome.

Fliegerova K, Mahayri T, Sechovcova H, Mekadim C, Mrazek J, Jarosikova R Front Microbiol. 2025; 15():1451054.

PMID: 39839113 PMC: 11747157. DOI: 10.3389/fmicb.2024.1451054.

Rat Fecal Metabolomics-Based Analysis.

Deda O, Gika H, Theodoridis G Methods Mol Biol. 2025; 2891():153-163.

PMID: 39812981 DOI: 10.1007/978-1-0716-4334-1_8.

References

Lynch S, Pedersen O . The Human Intestinal Microbiome in Health and Disease. N Engl J Med. 2016; 375(24):2369-2379. DOI: 10.1056/NEJMra1600266. View

de Vos W, Nieuwdorp M . Genomics: A gut prediction. Nature. 2013; 498(7452):48-9. DOI: 10.1038/nature12251. View

Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S . Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015; 528(7581):262-266. PMC: 4681099. DOI: 10.1038/nature15766. View

Wu H, Esteve E, Tremaroli V, Khan M, Caesar R, Manneras-Holm L . Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med. 2017; 23(7):850-858. DOI: 10.1038/nm.4345. View

Org E, Blum Y, Kasela S, Mehrabian M, Kuusisto J, Kangas A . Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort. Genome Biol. 2017; 18(1):70. PMC: 5390365. DOI: 10.1186/s13059-017-1194-2. View

Brial F, Le Lay A, Dumas M, Gauguier D . Implication of gut microbiota metabolites in cardiovascular and metabolic diseases. Cell Mol Life Sci. 2018; 75(21):3977-3990. PMC: 6182343. DOI: 10.1007/s00018-018-2901-1. View

Canfora E, Jocken J, Blaak E . Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol. 2015; 11(10):577-91. DOI: 10.1038/nrendo.2015.128. View

Wang Z, Klipfell E, Bennett B, Koeth R, Levison B, DuGar B . Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011; 472(7341):57-63. PMC: 3086762. DOI: 10.1038/nature09922. View

Pedersen H, Gudmundsdottir V, Nielsen H, Hyotylainen T, Nielsen T, Jensen B . Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016; 535(7612):376-81. DOI: 10.1038/nature18646. View

10.

Ridaura V, Faith J, Rey F, Cheng J, Duncan A, Kau A . Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013; 341(6150):1241214. PMC: 3829625. DOI: 10.1126/science.1241214. View

11.

Dodd D, Spitzer M, Van Treuren W, Merrill B, Hryckowian A, Higginbottom S . A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature. 2017; 551(7682):648-652. PMC: 5850949. DOI: 10.1038/nature24661. View

12.

Liu R, Hong J, Xu X, Feng Q, Zhang D, Gu Y . Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017; 23(7):859-868. DOI: 10.1038/nm.4358. View

13.

Koh A, Molinaro A, Stahlman M, Khan M, Schmidt C, Manneras-Holm L . Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1. Cell. 2018; 175(4):947-961.e17. DOI: 10.1016/j.cell.2018.09.055. View

14.

Edgar R . Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010; 26(19):2460-1. DOI: 10.1093/bioinformatics/btq461. View

15.

Caporaso J, Kuczynski J, Stombaugh J, Bittinger K, Bushman F, Costello E . QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010; 7(5):335-6. PMC: 3156573. DOI: 10.1038/nmeth.f.303. View

16.

Lozupone C, Knight R . UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol. 2005; 71(12):8228-35. PMC: 1317376. DOI: 10.1128/AEM.71.12.8228-8235.2005. View

17.

McDonald D, Price M, Goodrich J, Nawrocki E, DeSantis T, Probst A . An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2011; 6(3):610-8. PMC: 3280142. DOI: 10.1038/ismej.2011.139. View

18.

Langille M, Zaneveld J, Caporaso J, McDonald D, Knights D, Reyes J . Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013; 31(9):814-21. PMC: 3819121. DOI: 10.1038/nbt.2676. View

19.

Parks D, Tyson G, Hugenholtz P, Beiko R . STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics. 2014; 30(21):3123-4. PMC: 4609014. DOI: 10.1093/bioinformatics/btu494. View

20.

Liu H, Chen X, Hu X, Niu H, Tian R, Wang H . Alterations in the gut microbiome and metabolism with coronary artery disease severity. Microbiome. 2019; 7(1):68. PMC: 6486680. DOI: 10.1186/s40168-019-0683-9. View